.png){kind=icon}
.png){kind=icon}
Return
CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1
.png){kind=icon}
OA
AI
J
L
J
W
D
D
DOI：10.1074/jbc.M605040200.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
CD36 is necessary for inhibition of some angiogenic responses by the matricellular glycoprotein thrombospondin-1 and is therefore assumed to be the receptor that mediates its anti-angiogenic activities. Although ligation of CD36 by antibodies, recombinant type 1 repeats of thrombospondin-1, or CD36-binding peptides was sufficient to inhibit nitric oxide (NO)-stimulated responses in both endothelial and vascular smooth muscle cells, picomolar concentrations of native thrombospondin-1 similarly inhibited NO signaling in vascular cells from wild-type and CD36-null mice. Ligation of the thrombospondin-1 receptor CD47 by recombinant C-terminal regions of thrombospondin-1, thrombospondin-1 peptides, or CD47 antibodies was also sufficient to inhibit NO-stimulated phenotypic responses and cGMP signaling in vascular cells. Thrombospondin-1 did not inhibit NO signaling in CD47-null vascular cells or NO-stimulated vascular outgrowth from CD47-null muscle explants in three-dimensional cultures. Furthermore, the CD36-binding domain of thrombospondin-1 and anti-angiogenic peptides derived from this domain failed to inhibit NO signaling in CD47-null cells. Therefore, ligation of either CD36 or CD47 is sufficient to inhibit NO-stimulated vascular cell responses and cGMP signaling, but only CD47 is necessary for this activity of thrombospondin-1 at physiological concentrations.
Keywords:
ENDOTHELIAL GROWTH-FACTOR
INTEGRIN-ASSOCIATED PROTEIN
FACTOR-INDUCED ANGIOGENESIS
C-TERMINAL DOMAIN
TYPE-1 REPEATS
IN-VITRO
RECEPTOR
ADHESION
ALPHA(V)BETA(3)
PROLIFERATION
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.9
Papers:
11.2W
Citations:
28.3W
Organization
No organization information available
Cited Papers